Literature DB >> 2744356

Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects.

S Bates1, P O Sjödén, J Fellenius, O Nyrén.   

Abstract

The etiology of gastric pain is an unsolved riddle, despite nearly a century of research. While much research and many pharmacologic treatment methods have been aimed at controlling acid secretion, the role of acid in reports of pain is unclear. In this study, 30 patients (10 with endoscopically verified duodenal ulcers, 10 with verified nonulcer dyspepsia, and 10 healthy volunteers) participated in a double-blind crossover study of the effects of ranitidine on pain reports after an injection of pentagastrin. The results showed that whereas pentagastrin caused a significant increase in gastric secretion, only the patients with nonulcer dyspepsia reported any appreciable pain before or after the injection. In addition, they chose more adjectives to describe their pain and reported more symptoms, especially directly after the injection. There were no significant differences between the drug and placebo conditions nor between the ulcer and healthy subjects. The role of acid in reported pain remains unclear.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744356     DOI: 10.1016/0016-5085(89)90073-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.

Authors:  M L Cloud; W W Offen
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

2.  From ischochymia to gastroparesis: proposed mechanisms and preferred management of dyspepsia over the centuries.

Authors:  Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2014-04-09       Impact factor: 3.199

3.  The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies.

Authors:  N J Talley; K Lauritsen
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

4.  Decrease of intragastric acidity in healthy subjects dosed with ranitidine 75 mg, cimetidine 200 mg, or placebo.

Authors:  Mark I Hamilton; Judy Sercombe; Roy E Pounder
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

5.  The Therapeutic and Diagnostic Value of 2-week High Dose Proton Pump Inhibitor Treatment in Overlapping Non-erosive Gastroesophageal Reflux Disease and Functional Dyspepsia Patients.

Authors:  Chatchai Kriengkirakul; Tanisa Patcharatrakul; Sutep Gonlachanvit
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

6.  Hypersensitivity to acid in ulcer-like functional dyspepsia.

Authors:  H J Son; P L Rhee; J J Kim; K C Koh; S W Paik; J C Rhee
Journal:  Korean J Intern Med       Date:  1997-06       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.